Remdesivir: Ask the Experts (8/5/2020)

ACPE Activity Number: None
Release Date: August 5, 2020
Expirations Date: August 5, 2023
Activity Type: Knowledge-based  
CE Credits: None
Activity Fee: Members/Non-Member – Free

Overview

The latest remdesivir information will be shared with participants, including a review of information about the remdesivir distribution process, utilization protocols implemented in some hospitals, and clinical considerations for remdesivir use. This one-hour session will consist of brief presentations by panelists followed by a facilitated 30-minute question-and-answer session with the panelists.

Join us as experts share their experiences managing the distribution and use of remdesivir and share their knowledge about remdesivir treatment in hospitalized COVID-19 patients.

Learning Objectives

After completing this activity, the learner should be able to…

  1. Recall the current process used to allocate and distribute remdesivir to hospitals
  2. Describe strategies to ensure equitable availability of remdesivir to patients
  3. Explain the role of remdesivir in treating hospitalized COVID-19 patients

Speakers

Erin Fox, PharmD, BCPS, FASHP 
Senior Pharmacy Director, Drug Information & Support Services
University of Utah Health
Salt Lake City, Utah

Mark Sullivan, PharmD, MBA, BCPS, FASHP 
Associate Chief Pharmacy Officer
Vanderbilt University Hospitals & Clinics
Nashville, TN

Curtis Collins PharmD, MS, BCPS (AQ-ID), FASHP
Infectious Diseases Clinical Specialist
St. Joseph Mercy Health
Ypsilanti, Michigan